How CRO’s Can Help You Navigate New Regulations in Pharmacovigilance
With significant developments being continually implemented within pharmacovigilance, sponsors and marketing authorisation holders across the globe must ensure they are up-to-date with the frequently changing…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 2
In our previous post, we discussed how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate rare disease clinical research. Yet, as…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 1
A few months ago, Medpace and the Cincinnati Children’s Hospital Medical Center presented a webinar on the importance of patient-centric clinical research. Over the next…
Q&A with Dr. Richard Scheyer: Novel Approaches to Confirming CNS Penetration and Target Engagement
Richard Scheyer, MD, Vice President, Medical Affairs at Medpace answers some questions about his upcoming presentation about CNS-targeted therapies at DIA 2018.
Q&A from the webinar: Understanding the Hidden Landmines in Medical Device Clinical Research
Medpace medical device experts—who are directly involved with clinical research—presented a webinar on how to avoid the hidden costs associated with conducting clinical trials. Audience…
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3
In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients…
Detection of Familial Hypercholesterolemia in South Africa via Cascade Screening
Experts in Familial hypercholesterolemia (FH) from the Medpace Central Lab were authors on a scientific poster presented at the American College of Cardiology’s 2018 Annual…
How to Identify, Enroll, and Retain Rare Disease Populations in Clinical Trials
Enrolling enough subjects into a rare disease study can seem like an insurmountable challenge, especially when you're looking at a subset of a rare disease,…
The Potential Power of the Human Microbiome for Drug Development
The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity…
Key Issues to Consider When Initiating a Clinical Trial
In a recent article published in the November 2017 edition of the European Biopharmaceutical Review, experts from Medpace discuss key issues that need to be…